<DOC>
	<DOC>NCT00457925</DOC>
	<brief_summary>This is a phase one study investigating the absorption, distribution, metabolism and excretion of GSK221149A in six healthy women of non-child bearing potential.</brief_summary>
	<brief_title>Absorption, Distribution, Metabolism And Excretion Study For GSK221149A</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor, Premature</mesh_term>
	<criteria>Inclusion criteria: Healthy adult, nonsmoking females Aged between 30 55 years old, and BMI of between 19 and 32 Not of childbearing potential Exclusion criteria: No clinically significant findings on clinical examination, medical examination and blood tests. Radiation exposure over previous 3 years is greater than 10mSv History of bleeding or gastric problems</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>absorption,</keyword>
	<keyword>metabolism,</keyword>
	<keyword>excretion</keyword>
	<keyword>distribution,</keyword>
</DOC>